Rhythm Pharmaceuticals, Inc.
RYTM
$90.51
$3.133.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 10.21% | -13.45% | 5.79% | -14.34% | 0.88% |
| Total Depreciation and Amortization | -10.53% | -19.79% | -1.04% | 0.00% | -0.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.47% | 24.20% | 10.45% | 20.33% | 3.59% |
| Change in Net Operating Assets | -122.24% | -31.34% | 157.21% | -177.48% | 117.15% |
| Cash from Operations | 4.63% | -14.19% | 42.22% | -114.12% | 25.26% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 112.71% | -555.90% | 117.78% | 17.28% | 123.30% |
| Cash from Investing | 112.32% | -555.90% | 117.78% | 17.28% | 123.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.74% | 5,559.92% | -90.72% | -11.92% | 622.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.05% | -28.58% | 6.13% | -21.19% | -14.15% |
| Cash from Financing | -101.56% | 21,393.70% | -102.74% | -15.21% | 1,438.04% |
| Foreign Exchange rate Adjustments | -78.95% | 208.96% | -13,850.00% | -100.20% | 262.02% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 200.00% |
| Net Change in Cash | 102.49% | -382.07% | 74.28% | -59.25% | 136.46% |